We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Imipramine Hydrochloride Tablets, USP, 25mg 100 tablets (Leading Pharma, LLC)
Section 19A approved medicine
Imipramine Hydrochloride Tablets, USP, 25mg 100 tablets (Leading Pharma, LLC)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN 20 605 457 430
Phone
1300 077 674
Approved until
Status
Current
Medicines in short supply/unavailable
TOFRANIL 25 imipramine hydrochloride 25mg tablet blister pack - ARTG 60673
Indication(s)
- Major depression
- Nocturnal enuresis (from the age of 5 years onwards and provided the possibility of organic causes has first been excluded)
Images
